Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death.
about
The effects of TLR activation on T-cell development and differentiationFoxp3+ regulatory T cells are required for recovery from severe sepsisInduction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 DiabetesRegulatory T cells suppress innate immunity in kidney ischemia-reperfusion injurySuppressed neutrophil function in children with acute lymphoblastic leukemia.An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growRegulatory T cells and Toll-like receptors: what is the missing link?CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIFLongitudinal relationship of early life immunomodulatory T cell phenotype and function to development of allergic sensitization in an urban cohortEducating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide.Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients.The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes.Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.Nonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi InfectionCCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis.Differential infiltration of neutrophils in T1-T2 versus T3-T4 oral squamous cell carcinomas: a preliminary study.Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms.Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions.Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharideCloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells.Understanding how lipopolysaccharide impacts CD4 T-cell immunityBurkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin.Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis.Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.Regulatory immune cells in kidney disease.IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells.The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease.Positive and negative influences of regulatory T cells on tumour immunity.Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injuryInterleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4+CD25+ Regulatory T Cells.Therapeutic manipulation of immune tolerance in allergic disease.Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease.Harnessing regulatory T cells to suppress asthma: from potential to therapy.Th17 cells and Tregs: unlikely allies.Insights into the role of Toll-like receptors in modulation of T cell responses.Systemic inflammation and ammonia in hepatic encephalopathy.
P2860
Q27001581-BFC7EAFD-C9CB-489D-9383-43A9B843C896Q27317316-D71812BE-0431-4D54-90EC-2B753413D95EQ28548359-A8C61440-645E-40BD-8C65-1432E27DAB8FQ30435312-33BEF362-7599-4924-9423-F6D49ADA3285Q33386096-0BD2BD6A-D2CF-4866-AA70-437C1881E6EBQ33598811-C6188331-D1CE-4C76-B17B-2AB4975B9402Q33798158-FB90EDF6-553F-4B24-B256-B21CE53C1DF7Q34055489-C8EF6884-93A7-4A26-9818-F275C1CE6220Q34164779-85D7257E-4839-404E-A4C4-A248ADBA62CCQ34171237-61E6AEC4-930E-4EDF-917F-A56EAA80E8D7Q34258820-DBFCBE62-B3FB-4FD4-AE01-73A4F735988EQ34599210-F2C818A5-1F9F-4341-999C-D35013D4E359Q34620962-A43DF341-72CE-4ED1-A3D5-B65094DADBB5Q35027578-A7D757AC-A0E5-42C2-A7FA-AFA747E91D3FQ35173250-F06C5BF5-DA9C-4D62-8B6B-F6D40A9A46B3Q35703434-B05A8E34-7683-4FBC-B0ED-58A224DC151FQ35807585-6C1EDC86-C05A-4C97-B52F-11838ECD4ED3Q36027826-3256BDF0-5293-4855-B94E-5DFCAC34A872Q36070023-5CCFFBFB-917E-4971-82A5-BC92BCC48F14Q36078180-1068110D-6A54-4E19-B90D-E298333E62B1Q36514686-853B0201-9259-497D-81D7-8588E7D69102Q36547133-D3F43A32-E117-4FCA-8D0C-559A8ED27C70Q36710590-18CB771D-472D-486F-B5FE-50B56D3F4B1BQ37015247-7354D8EE-F57F-4201-BCD0-633777D700F8Q37071100-C22704BA-D55F-48DB-BCDF-B3D0121806BDQ37077297-7D5214CE-0186-40CC-9D64-A96E668EFACFQ37140284-3CB67742-EE5D-4FD8-8616-144B45CA4A48Q37202746-2B1ADA14-1B7E-4EBF-9870-C2ED7B4A939FQ37272092-4985CC13-0932-43E5-A6EA-210C58725CDCQ37287156-C8EAAE79-83AE-4AF7-9EEB-DE196886A20CQ37294572-1CCC0215-35A6-41B2-8C3C-3BF01BC867D3Q37363024-96726741-1DEB-4036-B85B-69A4B6D9C77FQ37492932-EABDFC6C-468F-4F84-BD4B-4F378C9DDCAAQ37567423-888463D2-DC5B-4E7F-BD67-4EA66609B283Q37627723-44D20F72-B90B-4737-B5F3-DEE71AB15904Q37664079-1FCD7C56-C428-4CF7-B6A1-F03399349B68Q37680540-00A06EEB-43C1-43D5-8873-181E24349250Q37700178-7557343F-F5A8-4A4D-A3A3-EE219D756DA0Q37777344-CB333FC9-4A79-436E-9D02-107B82136C63Q38065978-832F4A0E-A7F1-4551-A44D-7F9626457644
P2860
Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@ast
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@en
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@nl
type
label
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@ast
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@en
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@nl
prefLabel
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@ast
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@en
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@nl
P2093
P1476
Lipopolysaccharide-activated C ...... ote their apoptosis and death.
@en
P2093
Andrzej Sasiak
Henryk Tchórzewski
Natalia Lewkowicz
Przemyslaw Lewkowicz
P304
P356
10.4049/JIMMUNOL.177.10.7155
P407
P577
2006-11-01T00:00:00Z